observed that down-regulation of FXR promoted the progression of CRC, whereas selective activation of intestinal FXR could restrict intestinal cancer stem cell proliferation and profoundly increased survival in APCmin/+ mouse models of adenoma (25). The gene discussed is NR1H4; the disease is adenoma.